Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia

NCT07495631 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, Adult

Interventions

DRUG: VDCLP+V
DRUG: 2VIP
DRUG: Consolidation Therapy
DRUG: Maintenance Therapy
DRUG: Blinatumomab
DRUG: Venetoclax
PROCEDURE: CNS Prophylaxis
PROCEDURE: CAR-T Cell Therapy
PROCEDURE: Hematopoietic Stem Cell Transplantation (HSCT)

Sponsor

Institute of Hematology & Blood Diseases Hospital, China